• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种新的方法学,用于在样本处理和储存过程中保持母体外周血游离胎儿 DNA 的原有比例和完整性。

A new methodology to preserve the original proportion and integrity of cell-free fetal DNA in maternal plasma during sample processing and storage.

机构信息

Research and Development Division, Streck Inc., La Vista, NE 68128, USA.

出版信息

Prenat Diagn. 2010 May;30(5):418-24. doi: 10.1002/pd.2484.

DOI:10.1002/pd.2484
PMID:20306459
Abstract

OBJECTIVE

To develop a standardized blood collection device that preserves fetal cell-free DNA and minimizes the cell-free DNA background in maternal plasma.

METHODS

Blood samples were drawn from healthy pregnant donors into K(3)EDTA (BD vacutainer) and Cell-free DNA BCT tubes (Streck, Inc.) and kept at ambient temperature. Plasma was separated by centrifugation and cell-free DNA was extracted. Cell-free DNA from plasma was quantified by quantitative real-time polymerase chain reaction.

RESULTS

Blood drawn into Cell-free DNA BCT tubes showed no change in the original proportion of fetal cell-free DNA during a 14-day storage period at ambient temperature. Conversely, maternal blood drawn into K(3)EDTA tubes showed a steady reduction in the original proportion of fetal cell-free DNA over the same time period. Using maternal plasma stored in Cell-free DNA BCT tubes for 14 days, fetal cell-free DNA was amplified 80-fold using whole genome amplification (WGA).

CONCLUSION

Using Streck's Cell-free DNA BCT tubes, it is possible to preserve the original proportion of fetal cell-free DNA for extended times as well as minimize the post-sampling maternal cell-free DNA background. Preserved in this way, fetal cell-free DNA can be amplified by WGA technology to be used in prenatal diagnostic tests.

摘要

目的

开发一种标准化的血液采集装置,以保存胎儿游离 DNA 并最大限度地减少母体外周血中游离 DNA 的背景。

方法

将健康孕妇的血液样本分别采集到 K(3)EDTA(BD vacutainer)和游离 DNA BCT 管(Streck,Inc.)中,并在室温下保存。通过离心分离血浆并提取游离 DNA。通过实时定量聚合酶链反应定量游离 DNA。

结果

在室温下储存 14 天期间,Cell-free DNA BCT 管中采集的血液中胎儿游离 DNA 的原始比例没有变化。相比之下,在同一时间内,K(3)EDTA 管中采集的母血中胎儿游离 DNA 的原始比例持续下降。使用在 Cell-free DNA BCT 管中储存 14 天的母体外周血,使用全基因组扩增(WGA)可将胎儿游离 DNA 扩增 80 倍。

结论

使用 Streck 的 Cell-free DNA BCT 管,不仅可以长时间保持胎儿游离 DNA 的原始比例,还可以最大限度地减少采样后母体外周血中游离 DNA 的背景。以这种方式保存的胎儿游离 DNA 可以通过 WGA 技术扩增,用于产前诊断测试。

相似文献

1
A new methodology to preserve the original proportion and integrity of cell-free fetal DNA in maternal plasma during sample processing and storage.一种新的方法学,用于在样本处理和储存过程中保持母体外周血游离胎儿 DNA 的原有比例和完整性。
Prenat Diagn. 2010 May;30(5):418-24. doi: 10.1002/pd.2484.
2
Feasibility study of using fetal DNA in maternal plasma for non-invasive prenatal diagnosis.利用孕妇血浆中胎儿DNA进行无创产前诊断的可行性研究。
Acta Obstet Gynecol Scand. 2007;86(5):535-41. doi: 10.1080/00016340601159124.
3
Influence of temperature during transportation on cell-free DNA analysis.运输过程中温度对游离 DNA 分析的影响。
Fetal Diagn Ther. 2012;31(2):122-8. doi: 10.1159/000335020. Epub 2012 Jan 19.
4
Maternal urine for prenatal diagnosis--an analysis of cell-free fetal DNA in maternal urine and plasma in the third trimester.用于产前诊断的孕妇尿液——孕晚期孕妇尿液和血浆中游离胎儿DNA的分析
Prenat Diagn. 2007 Dec;27(13):1219-23. doi: 10.1002/pd.1875.
5
Maternal smoking: effect on circulating cell-free fetal and total DNA levels in maternal plasma from the second trimester.孕妇吸烟:对孕中期孕妇血浆中循环游离胎儿DNA和总DNA水平的影响。
Obstet Gynecol. 2007 Dec;110(6):1358-63. doi: 10.1097/01.AOG.0000295654.55971.9f.
6
A prospective analysis of cell-free fetal DNA concentration in maternal plasma as an indicator for adverse pregnancy outcome.对母血中游离胎儿DNA浓度作为不良妊娠结局指标的前瞻性分析。
Prenat Diagn. 2006 Sep;26(9):831-6. doi: 10.1002/pd.1513.
7
Presence of fetal DNA in maternal plasma decades after pregnancy.妊娠数十年后母血中胎儿DNA的存在。
Hum Genet. 2002 Jun;110(6):587-91. doi: 10.1007/s00439-002-0725-3. Epub 2002 Apr 18.
8
Assessment of free fetal DNA concentration in maternal plasma during the first trimester of pregnancy: comparative study between EDTA and PPT tubes - pilot study.孕早期母血中游离胎儿DNA浓度的评估:乙二胺四乙酸(EDTA)管与血浆制备管(PPT)的比较研究——初步研究
J Matern Fetal Neonatal Med. 2015 Jan;28(2):172-6. doi: 10.3109/14767058.2014.908843. Epub 2014 May 14.
9
Optimizing blood collection, transport and storage conditions for cell free DNA increases access to prenatal testing.优化游离 DNA 的采集、运输和储存条件可增加产前检测的机会。
Clin Biochem. 2013 Aug;46(12):1099-1104. doi: 10.1016/j.clinbiochem.2013.04.023. Epub 2013 Apr 30.
10
Free fetal DNA in maternal plasma in anembryonic pregnancies: confirmation that the origin is the trophoblast.稽留流产孕妇血浆中的游离胎儿DNA:证实其来源为滋养层细胞。
Prenat Diagn. 2007 May;27(5):415-8. doi: 10.1002/pd.1700.

引用本文的文献

1
Dynamics and Half-Life of Cell-Free DNA After Exercise: Insights from a Fragment Size-Specific Measurement Approach.运动后游离DNA的动力学和半衰期:来自片段大小特异性测量方法的见解
Diagnostics (Basel). 2025 Jan 4;15(1):109. doi: 10.3390/diagnostics15010109.
2
Emerging frontiers of cell-free DNA fragmentomics.游离DNA片段组学的新兴前沿领域。
Extracell Vesicles Circ Nucl Acids. 2022 Dec 21;3(4):380-392. doi: 10.20517/evcna.2022.34. eCollection 2022.
3
Recent advances in liquid biopsy of central nervous system lymphomas: case presentations and review of the literature.
中枢神经系统淋巴瘤液体活检的最新进展:病例报告及文献复习。
Brain Tumor Pathol. 2024 Apr;41(2):85-91. doi: 10.1007/s10014-024-00483-y. Epub 2024 Apr 10.
4
Cell‑free fetal DNA at 11‑13 weeks of gestation is not altered in complicated pregnancies.妊娠11至13周时,游离胎儿DNA在复杂妊娠中未发生改变。
Biomed Rep. 2024 Mar 4;20(4):69. doi: 10.3892/br.2024.1757. eCollection 2024 Apr.
5
Pre-Analytical Evaluation of Streck Cell-Free DNA Blood Collection Tubes for Liquid Profiling in Oncology.用于肿瘤液体分析的Streck游离DNA血液采集管的分析前评估
Diagnostics (Basel). 2023 Mar 29;13(7):1288. doi: 10.3390/diagnostics13071288.
6
The Role of Cell-Free DNA in Cancer Treatment Decision Making.游离DNA在癌症治疗决策中的作用。
Cancers (Basel). 2022 Dec 12;14(24):6115. doi: 10.3390/cancers14246115.
7
Circulating Tumor DNA as a Cancer Biomarker: An Overview of Biological Features and Factors That may Impact on ctDNA Analysis.循环肿瘤DNA作为一种癌症生物标志物:生物学特征及可能影响ctDNA分析的因素概述
Front Oncol. 2022 Jul 20;12:943253. doi: 10.3389/fonc.2022.943253. eCollection 2022.
8
Clinical Testing for Tumor Cell-Free DNA: College of American Pathologists Proficiency Programs Reveal Practice Trends.肿瘤游离 DNA 临床检测:美国病理学家学院能力验证计划揭示实践趋势。
Arch Pathol Lab Med. 2023 Apr 1;147(4):425-433. doi: 10.5858/arpa.2021-0585-CP.
9
Noninvasive Fetal Sex Determination by Real-Time PCR and TaqMan Probes.通过实时荧光定量PCR和TaqMan探针进行无创胎儿性别鉴定。
Rep Biochem Mol Biol. 2020 Oct;9(3):315-323. doi: 10.29252/rbmb.9.3.315.
10
Validation of Cell-Free DNA Collection Tubes for Determination of EGFR Mutation Status in Liquid Biopsy from NSCLC Patients.用于测定非小细胞肺癌患者液体活检中EGFR突变状态的游离DNA收集管的验证
Oncol Ther. 2019 Dec;7(2):131-139. doi: 10.1007/s40487-019-00099-9. Epub 2019 Aug 19.